Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dominik Fischer, who completed his DPhil in our Department, received an extraordinary professorship at the Eberhard Karls University of Tübingen on Tuesday 7 July 2015.

In this clinical academic position, he will continue his work on retinal gene therapy at the Centre for Ophthalmology, Tübingen.

Dominik has been involved in pre-clinical and clinical gene therapy programmes in Professor Robert MacLaren’s group as MRC Clinical Research Training Fellow since 2012.

Professor Dominik Fischer is principal investigator of the first clinical retinal gene therapy trials in Germany with his team at the Universty Eye Hospital Tübingen.

Similar stories

Scientists uncover the role of neuronal networks in moving between wake and sleep states

Changes in the way that neurons communicate with each other affect our ability to move between sleep and wake states.

Professor Robert MacLaren receives Innovation Award

Professor Robert MacLaren is the winner of the Inspiring Leadership category in the Vice-Chancellor's Innovation Awards 2020 for his work on Nightstar, a retinal gene therapy company.

Seminar Summary: Interventions for improving chronic sleep disruption

DPhil student Lampros Bisdounis summarises a departmental seminar by Associate Professor Simon Kyle